LEASE OR RENTAL OF LABORATORY EQUIPMENT
Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCYFALLS CHURCH, VA, 22042, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

LEASE OR RENTAL OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT (W066)
Timeline
    Description

    The Defense Health Agency (DHA) is seeking to award a firm fixed price contract for the lease or rental of laboratory equipment, specifically a Vitros XT3400 Chemistry Analyzer System, along with associated reagents, maintenance services, training, and consumables for the 52nd Medical Clinic located in Spangdahlem, Germany. This procurement is critical to ensure uninterrupted laboratory services that directly impact patient care, and it will be awarded on a sole source basis to Ortho Clinical Diagnostics GMBH, as they are uniquely qualified to meet the requirements. The anticipated contract period is from September 30, 2025, to September 29, 2026, with four option years, and interested parties must submit inquiries in writing by August 15, 2025, to Judith S. Meynard at judith.s.meynard.ctr@mail.mil.

    Point(s) of Contact
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Special Notice
    Similar Opportunities
    Chemistry Analyzers for Naval Hospital Yokosuka
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is seeking to procure five chemistry analyzers for the Naval Hospital Yokosuka in Japan. The analyzers must meet specific technical requirements, including a Laboratory Information System with bidirectional interface capabilities, the ability to process various sample types, and features for critical value notifications, among others. These analyzers are crucial for efficient laboratory operations, enabling the hospital to manage a high volume of samples—up to 100,000 annually—while ensuring timely and accurate diagnostics. Interested vendors can reach out to Cassi Jo Newman at cassi.j.newman.civ@health.mil or Jeffrey Collins at JEFFREY.P.COLLINS20.CIV@HEALTH.MIL for further details.
    Coagulation Analyzers for Naval Hospital Yokosuka and Branch Clinic Iwakuni
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is seeking to procure three coagulation analyzers and associated reagents for the Naval Hospital Yokosuka and Branch Clinic Iwakuni in Japan. The analyzers must meet specific technical requirements, including Laboratory Information System connectivity, a Windows 11 user interface, and the capability to perform various coagulation tests, while adhering to size and power limitations due to laboratory constraints. These analyzers are critical for ensuring timely and accurate diagnostic capabilities in a military healthcare setting. Interested vendors should contact Cassi Jo Newman at cassi.j.newman.civ@health.mil or Jeff Collins at jeffrey.p.collins20.civ@health.mil for further details, with a delivery, installation, and validation deadline set for July 1, 2023.
    Beckman Coulter Hematology Analyzers and Reagents for Naval Hospitals Yokosuka and Okinawa
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is seeking to procure nine hematology analyzers and associated reagents for Naval Hospitals located in Yokosuka and Okinawa, Japan, as well as Branch Health Clinics in Atsugi, Sasebo, Iwakuni, Japan, and Diego Garcia, United Kingdom. These analyzers are critical for conducting Complete Blood Counts and other hematology tests, ensuring timely and accurate results for blood samples that cannot be transported over long distances without compromising their integrity. The contract requires that the analyzers be delivered, installed, and validated by January 1, 2023, and interested vendors can reach out to primary contact Cassi Jo Newman at cassi.j.newman.civ@health.mil or secondary contact Jeff Collins at jeffrey.p.collins20.civ@health.mil for further details.
    Sole Source - Urine Analyzers for NHCH
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is seeking to procure automated urine laboratory analyzers and associated supplies for the United States Naval Health Clinic Hawaii (NHCH) and Branch Health Clinic Kaneohe Bay. This procurement includes reagents, quality control, maintenance, and consumables, specifically two automated urine analyzers, which are critical for enhancing diagnostic capabilities in military healthcare settings. The contract has been awarded as a firm-fixed-price, sole source to Beckman Coulter, Inc., following the Simplified Acquisition Procedures due to a lack of additional interest from other parties. For further inquiries, interested parties can contact Michelle Sanders at michelle.e.sanders6.civ@health.mil or by phone at 210-952-8481.
    GEM4000 Analyzer Repair
    Buyer not available
    The Department of Defense, through the Naval Medical Research Center (NMRC), intends to award a sole-source contract for the urgent repair of a Werfen GEM4000 blood gas analyzer, which has experienced a CoOx hardware failure (error 264). This repair is critical as it has halted operations related to Animal Protocol 0226 at the Environmental Health Effects Laboratory in Dayton, Ohio, and can only be performed by the manufacturer, Werfen USA, due to the proprietary nature of the technology. The NMRC has confirmed that Werfen USA is the sole supplier capable of addressing this urgent need, and the contract will be awarded under FAR Part 12 for commercial items. Interested vendors must be registered in the Systems for Award Management (SAM) and can contact Deborah Sharpe at deborah.m.sharpe2.civ@health.mil or Michael Ponczeck at michael.ponczek@us.af.mil for further information.
    Immunohematology Blood-Grouping Analyzer Cost Per Test Contract (GSA eBuy)
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is seeking proposals for a Cost Per Test (CPT) contract to supply two automated immunohematology blood-grouping analyzers for the Naval Medical Center Portsmouth (NMCP). The contract includes the provision of analyzers, reagents, quality control materials, maintenance services, and consumables necessary for the Transfusion Services Division, which plays a critical role in ensuring safe and timely blood transfusions for patients. The analyzers must meet specific testing capabilities, including ABO/Rh typing and antibody screening, and comply with FDA and other regulatory standards, with a delivery period set from January 1, 2026, to December 31, 2026. Interested vendors must submit their quotations via GSA eBuy by December 9, 2025, at 10:00 p.m. ET, and all inquiries should be directed to Matthew Teel at matthew.d.teel.civ@health.mil.
    Justification & Approval for SP7000-23-P-0109, Continued Lease of 940 MFDs in Germany
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency, is seeking to continue the lease of 940 multi-functional devices (MFDs) in Germany under contract SP7000-23-P-0109. This procurement involves an up to five-month lease period, specifically from April 1, 2023, to August 31, 2023, to ensure ongoing support for essential office equipment. The leased MFDs play a critical role in facilitating various office functions, thereby enhancing operational efficiency within the department. Interested vendors can reach out to Angeline Graff at angeline.graff@dla.mil or by phone at 717-770-7436, or Matthew O'Brien at matthew.obrien@dla.mil for further details regarding this opportunity.
    6640--BioPlex 2200 supplies
    Buyer not available
    The Department of Veterans Affairs, through the Network Contracting Office 6, is seeking qualified businesses to provide the BioRad BioPlex 2200 analyzer and associated supplies for the Durham VA Medical Center. The procurement aims to acquire an automated immunoassay analyzer capable of performing a wide range of tests, including Total Syphilis, 5th Generation HIV Ag/Ab, and various autoimmune assays, which are critical for enhancing operational efficiency and improving patient outcomes. Vendors must supply FDA-approved equipment and consumables, with an estimated annual testing volume of 20,000 patient tests, and the analyzer must be less than two years old. Interested parties are required to submit a capabilities statement and proof of authorized distributorship of BioRad by December 8, 2025, at 12 PM Eastern Time to Byron Brown at Byron.Brown4@va.gov.
    Intent to Sole Source to Ortho Clinical Diagnostics
    Buyer not available
    The Department of Health and Human Services, specifically the Indian Health Service, intends to award a sole source contract to Ortho Clinical Diagnostics for the renewal of a cost-per-test/lease agreement for two Vitros XT 7600 Integrated Chemistry systems at the Chinle Comprehensive Health Care Facility Laboratory Department in Arizona. This procurement is critical to ensure uninterrupted laboratory services that directly impact patient care, as the facility is already equipped with the analyzers and staff trained on their operation. The contract period is set from January 1, 2026, to December 31, 2026, with two optional one-year extensions, and interested parties may contact Nora Nutlouis at nora.nutlouis@ihs.gov or 928-725-9806 for further information. Responses to this notice must be submitted by the specified deadline to be considered for any future competitive procurement decisions.
    Preventative Maintenance and Repair of Sterilization and Central Vacuum Equipment in Biosafety Labs (BSL) 1,2,3 and 4
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking information from potential sources for a service contract focused on the preventative maintenance and repair of sterilization and central vacuum equipment in Biosafety Labs (BSL) 1, 2, 3, and 4. The contract will encompass the maintenance of 63 sterilization units, including 49 existing Getinge sterilizers, with an emphasis on adhering to original equipment manufacturer (OEM) specifications and conducting bacteriological indicator tests to ensure efficacy. This initiative is critical for maintaining essential sterilization and washing systems that support the mission of the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) in protecting warfighters from biological threats. Interested parties, particularly small businesses registered under NAICS code 811210, are encouraged to submit capability statements by December 12, 2025, to Christina Lewis at christina.m.lewis14.civ@health.mil or Emily K. O'Hara at Emily.K.OHara.civ@health.mil.